Eliud Kipchoge is training with Abbott’s Libre Sense to monitor his glucose levels to help him achieve optimal athletic performance.
Abbott (NYSE:ABT) Chairman & CEO Robert B. Ford highlighted what the future holds as he presented the first healthcare keynote ever at CES.
Speaking at the Consumer Electronics Show (CES) 2022 event, Ford headlined the “Human-Powered Health: Unlocking the Possibility of You” event, announcing that Abbott is developing a new category of biowearables called “Lingo.”